Erik Ingelsson
Patrimonio netto: 578 145 $ in data 31/05/2026
Patrimonio netto: 578 145 $ in data 31/05/2026
Erik Ingelsson currently works at Wave Life Sciences Ltd., as Chief Scientific Officer from 2024.
Dr. Ingelsson also formerly worked at GSK Plc, as Senior Vice President & Head-Target Discovery and Stanford University, as Professor-Medicine from 2015 to 2019.
Dr. Ingelsson received his doctorate degree from the University of Uppsala.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/04/2026 | 87.864 ( 0,05% ) | 578 145 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Direttore Tecnico/Scientifico/R&S | 09/05/2024 |
| Società | Posizione | Fine |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2019 |
| GSK PLC | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale